ASX - By Stock
|
PAR |
Re:
Chart
|
|
hamman
|
4.2K |
3.8M |
16 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
16
|
|
ASX - By Stock
|
PAR |
Re:
How would involvement from a Venture capitalists or Private equity group look for Paradigm
|
|
hamman
|
59 |
18K |
15 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
59
|
18K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
1 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
974
|
325K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
6 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
974
|
325K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
974
|
325K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
1 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
974
|
325K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
AGM Meeting
|
|
hamman
|
92 |
33K |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
92
|
33K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
hamman
|
95 |
28K |
4 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
95
|
28K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
hamman
|
95 |
28K |
2 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
95
|
28K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
hamman
|
95 |
28K |
6 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
95
|
28K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm Competition
|
|
hamman
|
15 |
5.2K |
1 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
15
|
5.2K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR Capital Position and 2024 Raising Requirements
|
|
hamman
|
120 |
41K |
13 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
120
|
41K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Successful Placement and Fully Underwritten ANREO
|
|
hamman
|
191 |
56K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
191
|
56K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Successful Placement and Fully Underwritten ANREO
|
|
hamman
|
191 |
56K |
15 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
191
|
56K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
hamman
|
218 |
74K |
4 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
218
|
74K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
hamman
|
218 |
74K |
6 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
218
|
74K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
hamman
|
218 |
74K |
1 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
218
|
74K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
hamman
|
218 |
74K |
5 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
218
|
74K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
hamman
|
4.2K |
3.8M |
3 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Liquidation squeeze?
|
|
hamman
|
3 |
1.2K |
6 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
3
|
1.2K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
|
|
hamman
|
237 |
75K |
0 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
237
|
75K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
|
|
hamman
|
237 |
75K |
0 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
237
|
75K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
|
|
hamman
|
237 |
75K |
23 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
237
|
75K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
hamman
|
974 |
325K |
7 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
974
|
325K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Reports Second Quarter Financial Results
|
|
hamman
|
13 |
6.3K |
3 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
13
|
6.3K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
hamman
|
72 |
26K |
2 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
72
|
26K
|
2
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Broad High-Grade Lithium Intersections Continue at Andover
|
|
hamman
|
390 |
122K |
1 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
390
|
122K
|
1
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Broad High-Grade Lithium Intersections Continue at Andover
|
|
hamman
|
390 |
122K |
6 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
390
|
122K
|
6
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Broad High-Grade Lithium Intersections Continue at Andover
|
|
hamman
|
390 |
122K |
1 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
390
|
122K
|
1
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Broad High-Grade Lithium Intersections Continue at Andover
|
|
hamman
|
390 |
122K |
5 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
390
|
122K
|
5
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Broad High-Grade Lithium Intersections Continue at Andover
|
|
hamman
|
390 |
122K |
0 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
390
|
122K
|
0
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Broad High-Grade Lithium Intersections Continue at Andover
|
|
hamman
|
390 |
122K |
1 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
390
|
122K
|
1
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Broad High-Grade Lithium Intersections Continue at Andover
|
|
hamman
|
390 |
122K |
3 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
390
|
122K
|
3
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Broad High-Grade Lithium Intersections Continue at Andover
|
|
hamman
|
390 |
122K |
2 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
390
|
122K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR and the BML findings
|
|
hamman
|
31 |
9.9K |
1 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
31
|
9.9K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
|
|
hamman
|
294 |
116K |
2 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
294
|
116K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
|
|
hamman
|
294 |
116K |
6 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
294
|
116K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
|
|
hamman
|
294 |
116K |
10 |
10/04/23 |
10/04/23 |
ASX - By Stock
|
294
|
116K
|
10
|
|